Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 10—October 2020
Research Letter

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea

Mi Seon Han1, Moon-Woo Seong1, Namhee Kim, Sue Shin, Sung Im Cho, Hyunwoong Park, Taek Soo Kim, Sung Sup Park, and Eun Hwa ChoiComments to Author 
Author affiliations: Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, South Korea (M.S. Han, N. Kim, S. Shin, H. Park); Seoul National University College of Medicine, Seoul (M.-W. Seong, S. Shin, H. Park, T.S. Kim, S.S. Park, E.H. Choi); Seoul National University Hospital, Seoul (M.-W. Seong, S.I. Cho, T.S. Kim, S.S. Park); Seoul National University Children’s Hospital, Seoul (E.H. Choi)

Cite This Article


Along with positive SARS-CoV-2 RNA in nasopharyngeal swabs, viral RNA was detectable at high concentration for >3 weeks in fecal samples from 12 mildly symptomatic and asymptomatic children with COVID-19 in Seoul, South Korea. Saliva also tested positive during the early phase of infection. If proven infectious, feces and saliva could serve as transmission sources.

In the current pandemic of coronavirus disease (COVID-19), detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children suspected of having the disease is essential for both infection control and establishing a definite causal relationship in unprecedented cases (1,2). However, efforts are hindered by negative SARS-CoV-2 test results for respiratory specimens and possible cross-reactivity with other coronaviruses among seropositive cases (2,3). Little is known about the value of various samples other than nasopharyngeal or oropharyngeal swab specimens in diagnosing COVID-19 and understanding the viral dynamics of SARS-CoV-2 in children. Virus RNA was persistently detected in rectal swab specimens in a previous study, although the infectiousness of the virus is unknown (4). We analyzed the viral RNA load kinetics of SARS-CoV-2 in various clinical specimens in children with COVID-19.

In South Korea, all confirmed case-patients, regardless of disease severity, must be isolated in hospitals or isolation facilities. For this study, we included all children <18 years of age who were confirmed to have COVID-19 by positive results for SARS-CoV-2 in combined nasopharyngeal and oropharyngeal swab specimens and who were hospitalized in Seoul Metropolitan Government–Seoul National University Boramae Medical Center during March 8–April 28, 2020. We extracted RNA from clinical specimens and detected SARS-CoV-2 by using the Allplex 2019-nCoV Assay kit (Seegene, We performed quantitation of the viral RNA with a standard curve constructed using in vitro transcribed RNA. This study was approved by the institutional review board at SMG-SNU Boramae Medical Center; written consent was waived.

We included 12 children in the study; 9 were mildly symptomatic and 3 were asymptomatic (Appendix Table 1). Median age was 6.5 years (range 27 days–16 years). Nasopharyngeal swab specimens tested positive for SARS-CoV-2 RNA in all 12 children, and 11 (92%) had positive RNA in their fecal specimens (Appendix Table 2). We collected saliva samples from 11 children; 8 (73%) tested positive.


Thumbnail of Changes in severe acute respiratory syndrome coronavirus 2 viral RNA load in A) nasopharyngeal swabs, B) feces, and C) saliva of mildly symptomatic and asymptomatic children with coronavirus disease over time, South Korea. The thick red line indicates trend in viral RNA load over time, and the shaded areas represent 95% CIs. The dashed line indicates the detection limit (1.25 × 104 copies/mL). Specimens with undetectable viral RNA loads are shown under the dashed line. Days after on

Figure. Changes in severe acute respiratory syndrome coronavirus 2 viral RNA load in A) nasopharyngeal swabs, B) feces, and C) saliva of mildly symptomatic and asymptomatic children with coronavirus disease over time,...

Viral RNA load in the nasopharyngeal swabs peaked early at median 7.56 (range 6.19–10.56) log10 copies/mL and decreased over time (p<0.001 for trend) (Figure, panel A). The positivity of the specimens was 75% during week 2 and 55% during week 3 (Appendix Table 2). In comparison, the median initial fecal RNA load was 7.68 (range <4.10–10.27) log10 copies/mL and remained steadily high (p = 0.148 for trend) for >3 weeks (Figure, panel B). Fecal positivity remained >80%. The median RNA load in fecal samples was significantly higher than that for nasopharyngeal swab specimens during week 2 (7.26 vs. 6.19 log10 copies/mL; p = 0.006) and week 3 (7.61 versus 5.49 log10 copies/mL; p = 0.006). Except for 1 case, the RNA load in saliva declined rapidly with time (p = 0.003 for trend) (Figure, panel C). Positivity in saliva samples was 80% in week 1 but dropped sharply to 33% in week 2 and 11% in week 3.

We collected urine specimens from the 12 patients after a median of 3 (range 0–8) days and plasma specimens at 2 (range 0–8) days from onset. Of these, urine samples of 2 (17%) patients tested positive (median load 5.69 [range 3.82–7.55] log10 copies/mL). Only 1 (8%) patient, 27 days of age, had RNA detected in plasma.

Symptomatic children had higher initial RNA load in nasopharyngeal swab specimens than asymptomatic children (9.01 vs. 6.32 log10 copies/mL; p = 0.048). We observed no significant differences in feces and in saliva and no correlation between RNA load and age.

In this study, we detected SARS-CoV-2 RNA in feces of 92% of mildly ill or asymptomatic children with COVID-19. In addition, the RNA load in feces remained steadily high, whereas that in nasopharyngeal swab specimens and saliva declined with time in both symptomatic and asymptomatic children. The detection of SARS-CoV-2 RNA in feces does not necessarily mean that infectious virus is present; thus, lack of virus isolation in our study limits interpretation in the context of infectivity. However, viable virus was isolated in feces in previous studies, and infectivity was dependent on viral RNA load (3,5,6). Considering these findings, proper handwashing when changing diapers in infants and adequate hygiene measures in restrooms are recommended to prevent the potential spread of the virus among household contacts.

Our findings also suggest that feces is a promising and reliable source for detecting both current and recent SARS-CoV-2 infection because the viral RNA is present in high loads for a prolonged time. Fecal specimens could aid in seeking the etiologic relationship between COVID-19 and unexpected manifestations in children.

We also detected SARS-CoV-2 RNA in saliva during the early phase of the infection for a short period of time. Live virus was isolated in saliva in a previous study, and the possibility of airborne transmission of the virus through normal speaking has been raised (7,8). Although the viral load in saliva drops rapidly, our findings suggest the necessity for children to wear masks, especially in schools, where children would talk in close proximity.

Dr. Han is a clinical assistant professor in the Division of Pediatric Infectious Diseases, Department of Pediatrics at Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, South Korea. Her research interests include respiratory virus infections and infectious diseases in immunocompromised hosts.





  1. Riphagen  S, Gomez  X, Gonzalez-Martinez  C, Wilkinson  N, Theocharis  P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:16078. DOIPubMedGoogle Scholar
  2. Verdoni  L, Mazza  A, Gervasoni  A, Martelli  L, Ruggeri  M, Ciuffreda  M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; Epub ahead of print. DOIPubMedGoogle Scholar
  3. Wölfel  R, Corman  VM, Guggemos  W, Seilmaier  M, Zange  S, Müller  MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:4659. DOIPubMedGoogle Scholar
  4. Xu  Y, Li  X, Zhu  B, Liang  H, Fang  C, Gong  Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:5025. DOIPubMedGoogle Scholar
  5. Xiao  F, Sun  J, Xu  Y, Li  F, Huang  X, Li  H, et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis. 2020;26: Epub ahead of print. DOIPubMedGoogle Scholar
  6. Xiao  F, Tang  M, Zheng  X, Liu  Y, Li  X, Shan  H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:18311833.e3. DOIPubMedGoogle Scholar
  7. To  KK-W, Tsang  OT-Y, Chik-Yan Yip  C, Chan  K-H, Wu  T-C, Chan  JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;ciaa149; Epub ahead of print. DOIPubMedGoogle Scholar
  8. Stadnytskyi  V, Bax  CE, Bax  A, Anfinrud  P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci U S A. 2020;117:118757; Epub ahead of print. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2610.202449

Original Publication Date: June 04, 2020

1These authors contributed equally to this article.

Table of Contents – Volume 26, Number 10—October 2020

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Address for Correspondence: Eun Hwa Choi, Department of Pediatrics, Seoul National University Children’s Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea

Send To

10000 character(s) remaining.


Page created: June 02, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.